Literature DB >> 16461474

Modern management of arrhythmias.

M C S Hall1, D M Todd.   

Abstract

The specialist management of arrhythmias has changed significantly over the past decade. This article outlines current management strategies for atrial flutter and atrial fibrillation, with particular emphasis on curative strategies with catheter ablation and the recent data on rhythm compared with rate control strategies. The expanding role of catheter ablation in the treatment of a wide variety of supraventricular and ventricular arrhythmias is discussed. The current evidence for implantable cardioverter defibrillators in the prevention of sudden cardiac death is summarised. The article also highlights the increasing recognition of a number of inherited syndromes that predispose to sudden cardiac death (for example, Brugada and long QT syndromes).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16461474      PMCID: PMC2596702          DOI: 10.1136/pgmj.2005.033654

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  73 in total

1.  "Brugada" syndrome: clinical data and suggested pathophysiological mechanism.

Authors:  M Alings; A Wilde
Journal:  Circulation       Date:  1999-02-09       Impact factor: 29.690

2.  Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Douglas Packer; Allan Skanes
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

3.  The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome.

Authors:  K Matsuo; T Kurita; M Inagaki; M Kakishita; N Aihara; W Shimizu; A Taguchi; K Suyama; S Kamakura; K Shimomura
Journal:  Eur Heart J       Date:  1999-03       Impact factor: 29.983

4.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

5.  Local electrogram-based criteria of cavotricuspid isthmus block.

Authors:  D C Shah; A Takahashi; P Jaïs; M Hocini; J Clémenty; M Haïssaguerre
Journal:  J Cardiovasc Electrophysiol       Date:  1999-05

6.  Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation: observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation.

Authors:  A Nabar; L M Rodriguez; C Timmermans; A van den Dool; J L Smeets; H J Wellens
Journal:  Circulation       Date:  1999-03-23       Impact factor: 29.690

7.  Feasibility of a noncontact catheter for endocardial mapping of human ventricular tachycardia.

Authors:  R J Schilling; N S Peters; D W Davies
Journal:  Circulation       Date:  1999-05-18       Impact factor: 29.690

8.  Pulmonary vein ablation for idiopathic atrial fibrillation: six month outcome of first procedure in 100 consecutive patients.

Authors:  J P Bourke; A Dunuwille; D O'Donnell; S Jamieson; S S Furniss
Journal:  Heart       Date:  2005-01       Impact factor: 5.994

9.  Catheter ablation for atrial fibrillation in congestive heart failure.

Authors:  Li-Fern Hsu; Pierre Jaïs; Prashanthan Sanders; Stéphane Garrigue; Mélèze Hocini; Fréderic Sacher; Yoshihide Takahashi; Martin Rotter; Jean-Luc Pasquié; Christophe Scavée; Pierre Bordachar; Jacques Clémenty; Michel Haïssaguerre
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

10.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

View more
  3 in total

1.  Cell and gene therapy for arrhythmias: Repair of cardiac conduction damage.

Authors:  Yong-Fu Xiao
Journal:  J Geriatr Cardiol       Date:  2011-09       Impact factor: 3.327

2.  Taxol, a microtubule stabilizer, prevents ischemic ventricular arrhythmias in rats.

Authors:  Junjie Xiao; Huaming Cao; Dandan Liang; Ying Liu; Hong Zhang; Hong Zhao; Yi Liu; Jun Li; Biao Yan; Luying Peng; Zhaonian Zhou; Yi-Han Chen
Journal:  J Cell Mol Med       Date:  2010-06-17       Impact factor: 5.310

Review 3.  Advances in Cardiac Pacing: Arrhythmia Prediction, Prevention and Control Strategies.

Authors:  Mehrie Harshad Patel; Shrikanth Sampath; Anoushka Kapoor; Devanshi Narendra Damani; Nikitha Chellapuram; Apurva Bhavana Challa; Manmeet Pal Kaur; Richard D Walton; Stavros Stavrakis; Shivaram P Arunachalam; Kanchan Kulkarni
Journal:  Front Physiol       Date:  2021-12-02       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.